AusPAR: Lanadelumab

Australian Public Assessment Report

AusPAR

AusPAR: Lanadelumab [PDF, 1.69 MB]

AusPAR: Lanadelumab [Word, 2.37 MB]

Attachment: Product Information Lanadelumab [PDF, 248.57 KB]

Attachment: Product Information Lanadelumab [Word, 63.96 KB]

Device/Product Name

Takhzyro

Active ingredients

Lanadelumab

AusPAR Date

4 March 2020

Published

19 March 2020

Submission Number

PM-2017-01464-1-2

Submission Type

New biological entity

Decision

Approved